Wells Fargo lowered the firm’s price target on Bath & Body Works to $32 from $35 and keeps an Equal Weight rating on the shares. The firm is cautious into Q3 EPS, and is tapering its Q3 estimates and cutting Q4 numbers. The story continues to struggle to find a bottom, and following weak checks throughout Q3, Wells sees no catalyst for an inflection.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BBWI:
- VOO ETF Update, 10/31/2024
- Telsey names its Holiday 2024 Top Picks
- Bath & Body Works Leadership Change and Steady Financial Outlook
- Amentum to replace Bath & Body Works in S&P 500 at open on 9/30
- Bath & Body Works to replace Movado in S&P 600 at open on 10/1
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
